Cumulative Effect of Phosphorylation of pRB on Regulation of E2F Activity

REFERENCES

• Akiyama, T., T. Ohuchi, S. Sumida, K. Matsumoto, and J. Toyoshima 1992. Phosphorylation of the retinoblastoma protein by cdk2. Proc. Natl. Acad. Sci. USA 89:7900–7904.
   PubMed Web of Science ®Google Scholar
• Antelman, D., S. Perry, R. Hollingsworth, R. J. Gregory, B. Driscoll, Y. K. Fung, and J. Bookstein 1997. Engineered mutants of pRB with improved growth suppression potential. Oncogene 15:2855–2866.
   PubMedGoogle Scholar
• Bagchi, S., R. Weinmann, and J. Raychaudhuri 1991. The retinoblastoma protein copurifies with E2F-1, an E1A-regulated inhibitor of the transcription factor E2F. Cell 65:1063–1070.
   PubMed Web of Science ®Google Scholar
• Bandara, L. R., V. M. Buck, M. Zamanian, L. H. Johnston, and J. Thangue 1993. Functional synergy between DP-1 and E2F-1 in the cell cycle-regulating transcription factor DRTF1/E2F. EMBO J. 12:4317–4324.
   PubMed Web of Science ®Google Scholar
• Beijersbergen, R. L., R. M. Kerkhoven, L. Zhu, L. Carlee, P. M. Voorhoeve, and J. Bernards 1994. E2F-4, a new member of the E2F gene family, has oncogenic activity and associates with p107 in vivo. Genes Dev. 8:2680–2690.
   PubMed Web of Science ®Google Scholar
• Brehm, A., E. A. Miska, D. J. McCance, J. L. Reid, A. J. Bannister, and J. Kouzarides 1998. Retinoblastoma protein recruits histone deacetylase to repress transcription. Nature 391:597–601.
   PubMed Web of Science ®Google Scholar
• Bremner, R., B. L. Cohen, M. Sopta, P. A. Hamel, C. J. Ingles, B. L. Gallie, and J. Phillips 1995. Direct transcriptional repression by pRB and its reversal by specific cyclins. Mol. Cell Biol. 15:3256–3265.
   PubMedGoogle Scholar
• Buchkovich, K., L. A. Duffy, and J. Harlow 1989. The retinoblastoma protein is phosphorylated during specific phases of the cell cycle. Cell 58:1097–1105.
   PubMed Web of Science ®Google Scholar
• Cao, L., B. Faha, M. Dembski, L.-H. Tsai, E. Harlow, and J. Dyson 1992. Independent binding of the retinoblastoma protein and p107 to the transcription factor E2F. Nature 355:176–179.
   PubMedGoogle Scholar
• Chellappan, S., S. Hiebert, M. Mudryi, J. M. Horowitz, and J. Nevins 1991. The E2F transcription factor is a cellular target for the RB protein. Cell 65:1053–1061.
   PubMed Web of Science ®Google Scholar
• Chen, L. I., T. Nishinaka, K. Kwan, I. Kitabayashi, K. Yokoyama, Y.-H. F. Fu, S. Grunwald, and J. Chiu 1994. The retinoblastoma gene product RB stimulates Sp1 mediated transcription by liberating Sp1 from a negative regulator. Mol. Biol. Cell 14:4380–4389.
   Google Scholar
• Chen, P.-L., D. J. Riley, Y. Chen, and J. Lee 1996. Retinoblastoma protein positively regulates terminal adipocyte differentiation through direct interaction with C/EBPs. Genes Dev. 10:2794–2804.
   PubMedGoogle Scholar
• Chen, P.-L., D. J. Riley, S. Chen-Kiang, and J. Lee 1996. Retinoblastoma protein directly interacts with and activates the transcription factor NF-IL6. Proc. Natl. Acad. Sci. USA 93:465–469.
   PubMedGoogle Scholar
• Chen, P.-L., P. Scully, J.-Y. Shew, J. Y. J. Wang, and J. Lee 1989. Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193–1198.
   PubMed Web of Science ®Google Scholar
• Chow, K. N. B., and J. Dean 1996. Domains A and B in the RB pocket interact to form a transcriptional repressor motif. Mol. Cell. Biol. 16:4862–4868.
   PubMedGoogle Scholar
• Chow, K. N. B., P. Starostik, and J. Dean 1996. The Rb family contains a conserved cyclin-dependent-kinase-regulated transcriptional repressor motif. Mol. Cell. Biol. 16:7173–7181.
   PubMedGoogle Scholar
• Cobrinik, D., P. Whyte, D. S. Peeper, T. Jacks, and J. Weinberg 1993. Cell cycle-specific association of E2F with the p130 E1A-binding protein. Genes Dev. 7:2392–2404.
   PubMed Web of Science ®Google Scholar
• Connell-Crowley, L., J. W. Harper, and J. Goodrich 1997. Cyclin D1/cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation. Mol. Biol. Cell 8:287–301.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., Y. Fusuke, F. Ajchenbaum, J. D. Griffin, and J. Livingston 1992. The retinoblastoma-susceptibility gene product becomes phosphorylated in multiple stages during cell cycle entry and progression. Proc. Natl. Acad. Sci. USA 89:1795–1798.
   PubMed Web of Science ®Google Scholar
• DeCaprio, J. A., J. W. Ludlow, D. Lynch, Y. Furukawa, J. Griffin, H. Piwnica-Worms, C.-M. Huang, and J. Livingston 1989. The product of the retinoblastoma susceptibility gene has properties of a cell cycle regulatory element. Cell 58:1085–1095.
   PubMed Web of Science ®Google Scholar
• DeGregori, J., T. Kowalik, and J. Nevins 1995. Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes. Mol. Cell. Biol. 15:4215–4224.
   PubMed Web of Science ®Google Scholar
• Dowdy, S. F., P. W. Hinds, K. Louie, S. I. Reed, A. Arnold, and J. Weinberg 1993. Physical interaction of the retinoblastoma protein with human D cyclins. Cell 73:499–511.
   PubMed Web of Science ®Google Scholar
• Durfee, T., K. Becherer, P.-L. Chen, S.-H. Yeh, Y. Yang, A. E. Kilburn, W.-H. Lee, and J. Elledge 1993. The retinoblastoma protein associates with the protein phosphatase type 1 catalytic subunit. Genes Dev. 7:555–569.
   PubMed Web of Science ®Google Scholar
• Ewen, M., Y. Xing, J. B. Lawrence, and J. Livingston 1991. Molecular cloning, chromosomal mapping, and expression of p107, a retinoblastoma gene product-related protein. Cell 66:1155–1164.
   PubMed Web of Science ®Google Scholar
• Ewen, M. E, H. K. Sluss, C. J. Sherr, H. Matsushime, J.-Y. Kato, and J. Livingston 1993. Functional interactions of the retinoblastoma protein with mammalian D-type cyclins. Cell 73:487–497.
   PubMed Web of Science ®Google Scholar
• Flemington, E. K., S. H. Speck, W. G. Kaelin Jr.. 1993. E2F-1-mediated transactivation is inhibited by complex formation with the retinoblastoma susceptibility gene product. Proc. Natl. Acad. Sci. USA 90:6914–6918.
   PubMed Web of Science ®Google Scholar
• Ginsberg, D., G. Vairo, T. Chittenden, Z.-X. Xiao, G. Gu, K. L. Wydner, J. A. DeCaprio, J. B. Lawrence, and J. Livingston 1994. E2F-4, a new member of the E2F transcription factor family, interacts with p107. Genes Dev. 8:2665–2679.
   PubMed Web of Science ®Google Scholar
• Gu, W., J. W. Schneider, G. Condorelli, S. Kaushal, V. Mahdavi, and J. Nadal-Ginard 1993. Interaction of myogenic factors and the retinoblastoma protein mediates muscle cell commitment and differentiation. Cell 72:309–324.
   PubMed Web of Science ®Google Scholar
• Hagemeier, C., A. J. Bannister, A. Cook, and J. Kouzarides 1993. The activation domain of transcription factor PU.1 binds the retinoblastoma (RB) protein and the transcription factor TFIID in vitro: RB shows sequence similarity to TFIID and TFIIB. Proc. Natl. Acad. Sci. USA 90:1580–1584.
   PubMed Web of Science ®Google Scholar
• Hamel, P., R. M. Gill, R. A. Phillips, and J. Gallie 1992. Regions controlling hyperphosphorylation and conformation of the retinoblastoma gene product are independent of domains required for transcriptional repression. Oncogene 7:693–701.
   PubMedGoogle Scholar
• Hamel, P., R. M. Gill, R. A. Phillips, and J. Gallie 1992. Transcriptional repression of the E2-containing promoters EIIaE, c-myc, and RB1 by the product of the RB1 gene. Mol. Cell. Biol. 12:3431–3438.
   PubMed Web of Science ®Google Scholar
• Hamel, P. A., B. L. Cohen, L. M. Sorce, B. L. Gallie, and J. Phillips 1990. Hyperphosphorylation of the retinoblastoma gene product is determined by domains outside the simian virus 40 large-T-antigen-binding regions. Mol. Cell. Biol. 10:6586–6595.
   PubMed Web of Science ®Google Scholar
• Hannon, G. J., D. Demetrick, and J. Beach 1993. Isolation of the Rb-related p130 through its interaction with cdk2 and cyclins. Genes Dev. 7:2378–2391.
   PubMed Web of Science ®Google Scholar
• Hatakeyama, M., J. A. Brill, G. R. Fink, and J. Weinberg 1994. Collaboration of G1 cyclins in the functional inactivation of the retinoblastoma protein. Genes Dev. 8:1759–1771.
   PubMed Web of Science ®Google Scholar
• Hateboer, G., R. M. Kerkhoven, A. Shvarts, R. Bernards, and J. Beijersbergen 1996. Degradation of E2F by the ubiquitin-proteasome pathway: regulation by retinoblastoma family proteins and adenovirus transforming proteins. Genes Dev. 10:2960–2970.
   PubMed Web of Science ®Google Scholar
• Helin, K., E. Harlow, and J. Fattaey 1993. Inhibition of E2F-1 transactivation by direct binding of the retinoblastoma protein. Mol. Cell. Biol. 13:6501–6508.
   PubMed Web of Science ®Google Scholar
• Helin, K., J. A. Lees, M. Vidal, N. Dyson, E. Harlow, and J. Fattaey 1992. A cDNA encoding a pRB-binding protein with properties of the transcription factor E2F. Cell 70:337–350.
   PubMed Web of Science ®Google Scholar
• Helin, K., C.-L. Wu, A. R. Fattaey, J. A. Lees, B. D. Dynlacht, and J. Ngwu 1993. Heterodimerization of the transcription factors E2F-1 and DP-1 leads to cooperative trans-activation. Genes Dev. 7:1850–1861.
   PubMed Web of Science ®Google Scholar
• Herwig, S., and J. Strauss 1997. The retinoblastoma protein: a master regulator of cell cycle, differentiation and apoptosis. Eur. J. Biochem. 246:581–601.
   PubMedGoogle Scholar
• Hiebert, S. W., S. P. Chellappan, J. M. Horowitz, and J. Nevins 1992. The interaction of RB with E2F coincides with an inhibition of the transcriptional activity of E2F. Genes Dev. 6:177–185.
   PubMed Web of Science ®Google Scholar
• Hijmans, E. M., P. M. Voorhoeve, R. L. Beijersbergen, L. J. van’t Veer, and J. Bernards 1995. E2F-5, a new E2F family member that interacts with p130 in vivo. Mol. Cell. Biol. 15:3082–3089.
   PubMedGoogle Scholar
• Hinds, P. W., S. Mittnacht, V. Dulic, A. Arnold, S. I. Reed, and J. Weinberg 1992. Regulation of retinoblastoma protein functions by ectopic expression of human cyclins. Cell 70:993–1006.
   PubMed Web of Science ®Google Scholar
• Hofmann, F., F. Martelli, D. M. Livingston, and J. Wang 1996. The retinoblastoma gene product protects E2F-1 from degradation by the ubiquitin-proteasome pathway. Genes Dev. 10:2949–2959.
   PubMed Web of Science ®Google Scholar
• Horton, L. E., Y. Qian, and J. Templeton 1995. G1 cyclins control of the retinoblastoma gene product growth regulation activity via upstream mechanisms. Cell Growth Differ. 6:395–407.
   PubMedGoogle Scholar
• Hsieh, J.-K., S. Fredersdorf, T. Kouzarides, K. Martin, and J. Lu 1997. E2F1-induced apoptosis requires DNA binding but not transactivation and is inhibited by the retinoblastoma protein through direct interaction. Genes Dev. 11:1840–1852.
   PubMedGoogle Scholar
• Hu, Q., J. A. Lees, K. J. Buchkovich, and J. Harlow 1992. The retinoblastoma protein physically associates with the human cdc2 kinase. Mol. Cell. Biol. 12:971–980.
   PubMedGoogle Scholar
• Hurford, R. K., D. Cobrinik, M.-H. Lee, and J. Dyson 1997. pRB and p107/p130 are required for the regulated expression of different sets of E2F responsive genes. Genes Dev. 11:1447–1463.
   PubMed Web of Science ®Google Scholar
• Kato, J.-Y, H. Matsushime, S. W. Hiebert, M. E. Ewen, and J. Sherr 1993. Direct binding of cyclin D to the retinoblastoma gene product (pRb) and pRb phosphorylation by the cyclin D-dependent kinase CDK4. Genes Dev. 7:331–342.
   PubMed Web of Science ®Google Scholar
• Kim, S.-J., U. S. Onwuta, Y. I. Lee, R. Li, M. R. Botchan, and J. Robbins 1992. The retinoblastoma gene product regulates Sp1-mediated transcription. Mol. Cell. Biol. 12:2455–2463.
   PubMed Web of Science ®Google Scholar
• Kim, S.-J., S. Wagner, F. Liu, M. A. Reilly, P. D. Robbins, and J. Green 1992. Retinoblastoma gene product activates expression of the human TGF-beta 2 gene through transcription factor ATF-2. Nature 358:331–334.
   PubMed Web of Science ®Google Scholar
• Kitagawa, M., H. Higashi, H.-K. Jung, I. Suzuki-Takahashi, M. Ikeda, K. Tamai, J.-Y. Kato, K. Segawa, E. Yoshida, S. Nishimura, and J. Taya 1996. The consensus motif for phosphorylation by cyclin D1-cdk4 is different from that for phosphorylation by cyclin A/E-cdk2. EMBO J. 15:7060–7069.
   PubMed Web of Science ®Google Scholar
• Knudsen, E. S., and J. Wang 1996. Differential regulation of retinoblastoma protein function by specific cdk phosphorylation sites. J. Biol. Chem. 271:8313–8320.
   PubMed Web of Science ®Google Scholar
• Knudsen, E. S., and J. Wang 1997. Dual mechanisms for the inhibition of E2F binding to RB by cyclin-dependent kinase-mediated RB phosphorylation. Mol. Cell. Biol. 17:5771–5783.
   PubMed Web of Science ®Google Scholar
• Krek, W., D. M. Livingston, and J. Shirodkar 1993. Binding to DNA and the retinoblastoma gene product promoted by complex formation of different E2F family members. Science 262:1557–1560.
   PubMed Web of Science ®Google Scholar
• Larminie, C. G. C., C. A. Cairns, R. Mital, K. Martin, T. Kouzarides, S. P. Jackson, and J. White 1997. Mechanistic analysis of RNA polymerase III regulation by the retinoblastoma protein. EMBO J. 16:2061–2071.
   PubMed Web of Science ®Google Scholar
• LaThangue, N. B. 1996. E2F and the molecular mechanisms of early cell-cycle control. Biochem. Soc. Trans. 24:54–59.
   PubMedGoogle Scholar
• Lee, J.-O., A. A. Russo, and J. Pavletich 1998. Structure of the retinoblastoma tumor-suppressor pocket domain bound to a peptide from HPV E7. Nature 391:859–865.
   PubMed Web of Science ®Google Scholar
• Lees, J. A., K. J. Buchkovich, D. R. Marshak, C. W. Anderson, and J. Harlow 1991. The retinoblastoma protein is phosphorylated on multiple sites by human cdc2. EMBO J. 10:4279–4290.
   PubMed Web of Science ®Google Scholar
• Lees, J. A., M. Saito, M. Vidal, M. Valentine, T. Look, E. Harlow, N. Dyson, and J. Helin 1993. The retinoblastoma protein binds to a family of transcription factors. Mol. Cell. Biol. 13:7813–7825.
   PubMed Web of Science ®Google Scholar
• Li, Y., C. Graham, S. Lacy, A. M. V. Duncan, and J. Whyte 1993. The adenovirus E1a-associated 130-kD protein is encoded by a member of the retinoblastoma gene family and physically interacts with cyclins A and E. Genes Dev. 7:2366–2377.
   PubMed Web of Science ®Google Scholar
• Lin, B. T.-Y., S. Gruenwald, A. O. Morla, W.-H. Lee, and J. Wang 1991. Retinoblastoma cancer suppressor gene product is a substrate of the cell cycle regulator cdc2 kinase. EMBO J. 10:857–864.
   PubMed Web of Science ®Google Scholar
• Ludlow, J. W., J. A. DeCaprio, C. Huang, W.-H. Lee, E. Paucha, and J. Livingston 1989. SV40 large T antigen binds preferentially to an underphosphorylated member of the retinoblastoma susceptibility gene product family. Cell 56:57–65.
   PubMed Web of Science ®Google Scholar
• Ludlow, J. W., C. L. Glendening, D. M. Livingston, and J. DeCaprio 1993. Specific enzymatic dephosphorylation of the retinoblastoma protein. Mol. Cell. Biol. 13:367–372.
   PubMed Web of Science ®Google Scholar
• Lundberg, A. S., and J. Weinberg 1998. Functional inactivation of the retinoblastoma protein requires sequential modification by at least two distinct cyclin-cdk complexes. Mol. Cell. Biol. 18:753–761.
   PubMed Web of Science ®Google Scholar
• Luo, R. X., A. A. Postigo, and J. Dean 1998. Rb interacts with histone deacetylase to repress transcription. Cell 92:463–473.
   PubMed Web of Science ®Google Scholar
• Magnaghi-Jaulin, L., R. Groisman, I. Naguibneva, P. Robin, S. Lorain, J. P. L. Villain, F. Troalen, D. Trouche, and J. Harel-Bellan 1998. Retinoblastoma protein represses transcription by recruiting a histone deacetylase. Nature 391:601–605.
   PubMed Web of Science ®Google Scholar
• Mayol, X., X. Grana, A. Baldi, N. Sang, Q. Hu, and J. Giordano 1993. Cloning of a new member of the retinoblastoma gene family (pRb2) which binds to the E1A transforming domain. Oncogene 8:2561–2566.
   PubMed Web of Science ®Google Scholar
• Mittnacht, S., J. A. Lees, D. Desai, E. Harlow, D. O. Morgan, and J. Weinberg 1994. Distinct sub-populations of the retinoblastoma protein show a distinct pattern of phosphorylation. EMBO J. 13:118–127.
   PubMed Web of Science ®Google Scholar
• Moberg, K., M. A. Starz, and J. Lees 1996. E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry. Mol. Cell. Biol. 16:1436–1449.
   PubMed Web of Science ®Google Scholar
• Moreno, S., and J. Nurse 1990. Substrates for p34cdc2: in vivo veritas? Cell 61:549–551.
   PubMed Web of Science ®Google Scholar
• Nevins, J. R. 1992. E2F: a link between the Rb tumor suppressor protein and viral oncoproteins. Science 258:424–429.
   PubMed Web of Science ®Google Scholar
• Qian, Y., C. Luckey, L. Horton, M. Esser, and J. Templeton 1992. Biological function of the retinoblastoma protein requires distinct domains for hyperphosphorylation and transcription factor binding. Mol. Cell. Biol. 12:5363–5372.
   PubMed Web of Science ®Google Scholar
• Qin, X.-Q., D. M. Livingston, W. G. Kaelin Jr., and J. Adams 1994. Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. Proc. Natl. Acad. Sci. USA 91:10918–10922.
   PubMed Web of Science ®Google Scholar
• Sambrook, J., E. F. Fritsch, T. Maniatis 1989. Molecular cloning: a laboratory manual, 2nd ed. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, N.Y.
   Google Scholar
• Sardet, C., M. Vidal, D. Cobrinik, Y. Geng, C. Onufryk, A. Chen, and J. Weinberg 1995. E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle. Proc. Natl. Acad. Sci. USA 92:2403–2407.
   PubMedGoogle Scholar
• Scheffner, M., K. Munger, J. C. Byrne, and J. Howley 1991. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc. Natl. Acad. Sci. USA 88:5523–5527.
   PubMed Web of Science ®Google Scholar
• Sellers, W. R., and J. Kaelin 1996. RB as a modulator of transcription. Biochim. Biophys. Acta 1288:M1–M5.
   PubMedGoogle Scholar
• Sellers, W. R., B. G. Novitch, S. Miyake, A. Heith, G. A. Otterson, F. J. Kaye, A. B. Lassar, W. G. Kaelin Jr.. 1998. Stable binding to E2F is not required for the retinoblastoma protein to activate transcription, promote differentiation, and suppress tumor cell growth. Genes Dev. 12:95–106.
   PubMed Web of Science ®Google Scholar
• Shirodkar, S., M. Ewen, J. A. DeCaprio, J. Morgan, D. M. Livingston, and J. Chittenden 1992. The transcription factor E2F interacts with the retinoblastoma product and a p107-cyclin A complex in a cell cycle-regulated manner. Cell 68:157–166.
   PubMed Web of Science ®Google Scholar
• Sidle, A., C. Palaty, P. Dirks, O. Wiggan, M. Kiess, R. M. Gill, A. K. Wong, and J. Hamel 1996. Activity of the retinoblastoma family proteins, pRB, p107, and p130, during cellular proliferation and differentiation. Crit. Rev. Biochem. Mol. Biol. 31:237–271.
   PubMed Web of Science ®Google Scholar
• Singh, P., J. Coe, and J. Hong 1995. A role for retinoblastoma protein in potentiating transcriptional activation by the glucocorticoid receptor. Nature 374:562–565.
   PubMedGoogle Scholar
• Sleigh, M. J. 1986. A nonchromatographic assay for expression of the chloramphenicol acetyltransferase gene in eukaryotic cells. Anal. Biochem. 156:251–256.
   PubMed Web of Science ®Google Scholar
• Tao, Y., R. F. Kassatly, W. D. Cress, and J. Horowitz 1997. Subunit composition determines E2F DNA-binding site specificity. Mol. Cell. Biol. 17:6994–7007.
   PubMed Web of Science ®Google Scholar
• Templeton, D. J., S. H. Park, L. Lanier, and J. Weinberg 1991. Nonfunctional mutants of the retinoblastoma protein are characterized by defects in phosphorylation, viral oncoprotein association, and nuclear tethering. Proc. Natl. Acad. Sci. USA 88:3033–3037.
   PubMed Web of Science ®Google Scholar
• Udvadia, A. J., K. T. Rogers, P. D. R. Higgins, Y. Murata, K. H. Martin, P. A. Humphrey, and J. Horowitz 1993. Sp-1 binds promoter elements regulated by the RB protein and Sp-1 mediated transcription is stimulated by RB coexpression. Proc. Natl. Acad. Sci. USA 90:3265–3269.
   PubMed Web of Science ®Google Scholar
• Vairo, G., D. M. Livingston, and J. Ginsberg 1995. Functional interaction between E2F-4 and p130: evidence for distinct mechanisms underlying growth suppression by different retinoblastoma protein family members. Genes Dev. 9:869–881.
   PubMed Web of Science ®Google Scholar
• Voit, R., K. Schafer, and J. Grummt 1997. Mechanism of repression of RNA polymerase I transcription by the retinoblastoma gene. Mol. Cell. Biol. 17:4230–4237.
   PubMedGoogle Scholar
• Wang, C.-Y., B. Petryniak, C. B. Thompson, W. G. Kaelin, and J. Leiden 1993. Regulation of the Ets-related transcription factor Elf-1 by binding to the retinoblastoma protein. Science 260:1330–1335.
   PubMed Web of Science ®Google Scholar
• Weintraub, S. J., K. N. B. Chow, R. X. Luo, S. H. Zhang, S. He, and J. Dean 1995. Mechanism of active transcriptional repression by the retinoblastoma protein. Nature 375:812–815.
   PubMed Web of Science ®Google Scholar
• Zamanian, M., and J. Thangue 1993. Transcriptional repression by the Rb-related protein p107. Mol. Cell. Biol. 4:389–396.
   Google Scholar
• Zarkowska, T., and J. Mittnacht 1997. Differential phosphorylation of the retinoblastoma protein by G1/S cyclin dependent kinases. J. Biol. Chem. 272:12738–12746.
   PubMed Web of Science ®Google Scholar
• Zarkowska, T., S. U., E. Harlow, and J. Mittnacht 1997. Monoclonal antibodies specific for underphosphorylated retinoblastoma protein identify a cell cycle regulated phosphorylation site targeted by CDKs. Oncogene 14:249–254.
   PubMed Web of Science ®Google Scholar
• Zhu, L., S. van den Heuvel, K. Helin, A. Fattaey, M. Ewen, D. Livingston, N. Dyson, and J. Harlow 1993. Inhibition of cell proliferation by p107, a relative of the retinoblastoma protein. Genes Dev. 7:1111–1125.
   PubMed Web of Science ®Google Scholar